Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled time : 12:00 source : Ir.kalvista.com save search
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2023-05-02 (Crawled : 12:00) - ir.kalvista.com
KALV | $11.59 0.78% 0.78% 350K
|
Health Technology
|
| O: -0.11%
H: 1.58%
C: 0.45%
nasdaq pharmaceuticals grants
KalVista Pharmaceuticals Reports Third Fiscal Quarter Results
Published: 2023-03-09 (Crawled : 12:00) - ir.kalvista.com
KALV | $11.59 0.78% 0.78% 350K
|
Health Technology
|
| O: 1.29%
H: 5.08%
C: -6.61%
pharmaceuticals results
KalVista Pharmaceuticals Presents Data at American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting
Published: 2023-02-27 (Crawled : 12:00) - ir.kalvista.com
KALV | $11.59 0.78% 0.78% 350K
|
Health Technology
|
| O: -0.53%
H: 1.34%
C: -1.88%
pharmaceuticals immunology meeting
KalVista Pharmaceuticals to Present Data at the 2023 American Academy of Allergy, Asthma & Immunology
Published: 2023-02-16 (Crawled : 12:00) - ir.kalvista.com
KALV | $11.59 0.78% 0.78% 350K
|
Health Technology
|
| O: 1.68%
H: 0.0%
C: -3.05%
pharmaceuticals immunology
KalVista Pharmaceuticals Provides Progress Updates on Sebetralstat Development
Published: 2023-02-14 (Crawled : 12:00) - ir.kalvista.com
KALV | $11.59 0.78% 0.78% 350K
|
Health Technology
|
| O: -0.25%
H: 0.12%
C: -2.46%
pharmaceuticals sebetralstat
KalVista Pharmaceuticals Presents Data at Western Society of Allergy, Asthma & Immunology (WSAAI) 60th Annual Scientific Session
Published: 2023-02-07 (Crawled : 12:00) - ir.kalvista.com
KALV | $11.59 0.78% 0.78% 350K
|
Health Technology
|
| O: 2.48%
H: 1.09%
C: 0.73%
pharmaceuticals immunology
KalVista Pharmaceuticals to Present at SVB Securities Global Biopharma Conference
Published: 2023-02-03 (Crawled : 12:00) - ir.kalvista.com
KALV | $11.59 0.78% 0.78% 350K
|
Health Technology
|
| O: -1.05%
H: 5.97%
C: 4.38%
biopharma pharmaceuticals global conference
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2023-02-02 (Crawled : 12:00) - ir.kalvista.com
KALV | $11.59 0.78% 0.78% 350K
|
Health Technology
|
| O: 0.79%
H: 1.3%
C: -1.04%
pharmaceuticals nasdaq grants
KalVista Pharmaceuticals Announces Benjamin L. Palleiko Promoted to President
Published: 2023-01-05 (Crawled : 12:00) - ir.kalvista.com
KALV | $11.59 0.78% 0.78% 350K
|
Health Technology
|
| O: 0.59%
H: 0.29%
C: -4.69%
pharmaceuticals
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2023-01-04 (Crawled : 12:00) - ir.kalvista.com
KALV | $11.59 0.78% 0.78% 350K
|
Health Technology
|
| O: 0.45%
H: 3.9%
C: 1.8%
pharmaceuticals nasdaq grants
KalVista Pharmaceuticals Announces $58 Million Registered Direct Offering
Published: 2022-12-27 (Crawled : 12:00) - ir.kalvista.com
KALV | $11.59 0.78% 0.78% 350K
|
Health Technology
|
| O: 12.52%
H: 8.35%
C: 2.26%
offering pharmaceuticals direct
KalVista Pharmaceuticals Reports Second Fiscal Quarter Results
Published: 2022-12-08 (Crawled : 12:00) - ir.kalvista.com
KALV | $11.59 0.78% 0.78% 350K
|
Health Technology
|
| O: 0.77%
H: 4.57%
C: 4.19%
pharmaceuticals results
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-12-05 (Crawled : 12:00) - ir.kalvista.com
KALV | $11.59 0.78% 0.78% 350K
|
Health Technology
|
| O: -0.19%
H: 0.37%
C: -3.72%
pharmaceuticals nasdaq grants
KalVista Pharmaceuticals Presents Patient-Focused Data at American College of Allergy, Asthma & Immunology (ACAAI) 2022 Meeting
Published: 2022-11-14 (Crawled : 12:00) - ir.kalvista.com
KALV | $11.59 0.78% 0.78% 350K
|
Health Technology
|
| O: 0.18%
H: 0.54%
C: -4.72%
pharmaceuticals immunology meeting
KalVista Pharmaceuticals to Present at Upcoming Investor Conferences
Published: 2022-11-07 (Crawled : 12:00) - ir.kalvista.com
KALV | $11.59 0.78% 0.78% 350K
|
Health Technology
|
| O: 0.57%
H: 4.38%
C: 1.52%
pharmaceuticals
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-09-02 (Crawled : 12:00) - ir.kalvista.com
KALV | $11.59 0.78% 0.78% 350K
|
Health Technology
|
| O: 0.83%
H: 0.53%
C: -4.89%
nasdaq grants
KalVista Pharmaceuticals Provides Operational Update and Fiscal Year Financial Results
Published: 2022-07-07 (Crawled : 12:00) - ir.kalvista.com
KALV | $11.59 0.78% 0.78% 350K
|
Health Technology
|
| O: 0.4%
H: 12.34%
C: 9.25%
year update results
KalVista Pharmaceuticals Announces Initiation of KVD900 Phase 3 KONFIDENT Clinical Trial
Published: 2022-03-07 (Crawled : 12:00) - ir.kalvista.com
KALV | $11.59 0.78% 0.78% 350K
|
Health Technology
|
| O: -2.65%
H: 0.0%
C: 0.0%
kvd900 als trial phase 3
KalVista Pharmaceuticals Presents Data Demonstrating KVD900 Achieves Rapid Exposure and Improves Outcomes as Oral On-Demand Treatment of HAE
Published: 2021-11-08 (Crawled : 12:00) - ir.kalvista.com
KALV | $11.59 0.78% 0.78% 350K
|
Health Technology
|
| O: 1.83%
H: 0.0%
C: -2.51%
treatment ema
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.